| 1 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
-10,67 % |
+19,87 % |
-0,65 |
| 2 |
CH0113817123 |
Bellevue Biotech DT CHF |
-10,97 % |
+19,86 % |
-0,67 |
| 3 |
LU0133360163 |
Candriam Equities L Biotechnology, I - Capitalisation |
-10,90 % |
+19,70 % |
-0,67 |
| 4 |
LU1897414568 |
Janus Henderson Horizon Biotechnology Fund IU2 USD |
-16,65 % |
+27,20 % |
-0,70 |
| 5 |
LU1897414485 |
Janus Henderson Horizon Biotechnology Fund H2 USD |
-16,84 % |
+27,19 % |
-0,70 |
|
|
| 67 |
LU0889565759 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse I (acc) EUR-H1 |
-21,81 % |
+21,59 % |
-1,12 |
|
|
| 73 |
LU0774687577 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse Z (acc) GBP |
-23,25 % |
+20,32 % |
-1,26 |
| 74 |
LU0415392835 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating |
-15,07 % |
+13,54 % |
-1,28 |
| 75 |
LU0415392595 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating |
-15,66 % |
+13,54 % |
-1,33 |
| 76 |
DE000A3DCA95 |
BIT Biotech Opportunities S |
-39,71 % |
+30,67 % |
-1,37 |
| 77 |
DE000A3DCBA0 |
BIT Biotech Opportunities I-II |
-39,83 % |
+30,65 % |
-1,37 |